SARS CoV 2 News and Research

RSS

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

5 Jan 2024

COVID-19's unseen impact: study reveals surge in home deaths across 32 countries

Trends in places of death across 32 countries during and before the COVID-19.

5 Jan 2024

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.

From ATCC 5 Jan 2024

Gonorrhea cases surge 64% post-COVID lockdown in England, highlighting unintended STI suppression

A study analyzing data from the Genitourinary Medicine Clinic Activity Dataset in England shows a 64% increase in gonorrhea diagnoses following the relaxation of COVID-19 restrictions, despite only a 5.6% increase in STI testing, suggesting that social distancing may have suppressed STI transmission.

4 Jan 2024

AI model predicts future spread of SARS-CoV-2 variants using genomic data

Researchers developed an AI-based model to predict the spread of new SARS-CoV-2 variants, analyzing nine million genomic sequences across 30 countries and incorporating factors like vaccination rates and non-pharmaceutical interventions.

4 Jan 2024

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

4 Jan 2024

Unmasking the persistent threats of long-COVID's pulmonary sequelae

A collaborative study led by Dr. Estefanía Nova-Lamperti of the Universidad de Concepción, Dr. Gonzalo Labarca of Harvard University, and Mauricio Hernández, of MELISA Institute, and which included the participation of researchers from leading academic institutions, sought to identify the sequelae associated with long-term pulmonary dysfunction (L-PDD) in patients with COVID-19.

4 Jan 2024

Study identifies mitochondrial dysfunction as cause of long-COVID fatigue

Researchers from Amsterdam UMC and Vrije Universiteit Amsterdam (VU) have discovered that the persistent fatigue in patients with long-COVID has a biological cause, namely mitochondria in muscle cells that produce less energy than in healthy patients.

4 Jan 2024

Factors that increase the risk of severe COVID-19 in children

Study analyzes a nationwide cohort of hospitalized children and adolescents in Germany, identifying key risk factors for severe SARS-CoV-2 infection, including obesity, Trisomy 21, and neurological conditions.

3 Jan 2024

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

The current achievements in the development of a pan-coronavirus vaccine.

3 Jan 2024

Hybrid immunity's role in curbing COVID-19: Canadian study sheds light on vaccine-infection synergy

Study evaluates the impact of hybrid immunity on SARS-CoV-2 antibody levels in Canadian adults, revealing that hybrid immunity, combining vaccination and recovery from infection, significantly reduces COVID-19 morbidity and mortality.

2 Jan 2024

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

2 Jan 2024

AI tool tracks mutations to predict next COVID variant wave

An AI model can predict which SARS-CoV-2 variants are likely to cause new waves of infection. Current models used to predict the dynamics of viral transmission do not predict variant-specific spread.

2 Jan 2024

New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity

Very early in the COVID-19 pandemic clinical trials in patients hospitalized with COVID-19 confirmed that corticosteroids like dexamethasone reduced mortality, but they were harmful when applied at the first COVID-19 symptoms, due to the weakening of innate antiviral immunity, leading to delayed viral clearance and adverse outcomes in severe viral pneumonias.

28 Dec 2023

New vaccine design targets universal immunity with "chef"-inspired tool

Vaccine development aims at protecting as many people as possible from infections. Short protein fragments of pathogens, so-called epitopes, are seen as a promising new approach for vaccine development.

20 Dec 2023

NHS COVID-19 app study shows digital contact tracing's effectiveness in predicting virus transmission risks

A comprehensive study in the Nature journal analyzed over seven million data points from the NHS COVID-19 app, revealing how digital contact tracing can effectively predict SARS-CoV-2 transmission risks based on exposure duration and proximity.

20 Dec 2023

First case of COVID-caused vocal cord paralysis in teen reported by Mass Eye and Ear doctors

Physician-researchers from Mass Eye and Ear, a member of Mass General Brigham, report the first pediatric case of bilateral vocal cord paralysis after COVID-19 (SARS-CoV-2) infection.

19 Dec 2023

T-cells step up to offer protection against COVID-19 in B-cell deficient patients

B cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers -; such as rituximab (RTX) -; or from natural immune deficiency.

18 Dec 2023

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants like XBB.1.5, demonstrating its potential as a broadly effective and stable vaccine option.

18 Dec 2023

New Year's Eve celebrations linked to spike in COVID-19 cases: Small gatherings, not large events, the main culprit

Study investigates the impact of New Year's Eve celebrations on SARS-CoV-2 transmission in Belgium, revealing that small-scale social gatherings, rather than large events, significantly contributed to a surge in COVID-19 cases among higher education students.

18 Dec 2023

SARS CoV 2 News and Research

Stapled lipopeptides show promise as broad-spectrum antiviral agents

COVID-19's unseen impact: study reveals surge in home deaths across 32 countries

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

Gonorrhea cases surge 64% post-COVID lockdown in England, highlighting unintended STI suppression

AI model predicts future spread of SARS-CoV-2 variants using genomic data

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

Unmasking the persistent threats of long-COVID's pulmonary sequelae

Study identifies mitochondrial dysfunction as cause of long-COVID fatigue

Factors that increase the risk of severe COVID-19 in children

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

Hybrid immunity's role in curbing COVID-19: Canadian study sheds light on vaccine-infection synergy

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

AI tool tracks mutations to predict next COVID variant wave

New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity

New vaccine design targets universal immunity with "chef"-inspired tool

NHS COVID-19 app study shows digital contact tracing's effectiveness in predicting virus transmission risks

First case of COVID-caused vocal cord paralysis in teen reported by Mass Eye and Ear doctors

T-cells step up to offer protection against COVID-19 in B-cell deficient patients

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

New Year's Eve celebrations linked to spike in COVID-19 cases: Small gatherings, not large events, the main culprit

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News